|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.11 USD | -0.94% |
|
-3.65% | -29.90% |
| 05-06 | Omega Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 04-16 | Omega Therapeutics CFO Joshua Reed to Depart | MT |
Omega Therapeutics, Inc. announced the appointment of Joshua Reed as Chief Financial Officer, effective May 23, 2022. Roger Sawhney, M.D., Omega's Chief Financial Officer, will serve as Chief Business Officer.
| 1st Jan change | Capi. | |
|---|---|---|
| -29.90% | 117M | |
| +54.05% | 63.85B | |
| -2.02% | 41.83B | |
| +40.01% | 40.47B | |
| -10.22% | 27.17B | |
| +13.42% | 26.52B | |
| -21.60% | 18.69B | |
| +2.89% | 12.73B | |
| +22.40% | 12.11B | |
| +27.49% | 12.07B |
OMEGA THERAPEUTICS, INC. 
